SEARCH · PubMed Health

Results for “Pertussis Vaccine”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 19 recordsLinked to original sources

PubMed1979

Modification of antibody response to type III pneumopolysaccharide by route of injection of pertussis vaccine.

Pertussis vaccine (PV) or diphtheria toxoid-PV-tetanus toxoid (DPT) altered the antibody response of BALB/c female mice to type III pneumococcal polysaccharide antigen (S3). The key factor affecting the magnitude of the response to S3 was the route of injection of PV or DPT, whereas the route of injection of S3 was not crucial. Subcutaneous injections of DPT augmented the antibody response to low, optimal, and tolerogenic (high) doses of S3 injected either subcutaneously or intraperitoneally. This enhancement was persistent and was observed both when S3 and DPT were mixed and injected subcutaneously and when S3 and DPT were injected concurrently at separate subcutaneous sites. When either PV or DPT was injected intraperitoneally, the antibody response to subcutaneously or intraperitoneally injected S3 was significantly decreased. These experiments demonstrate a dichotomy of effect dependent on the route of administration of PV. Most studies in mice utilizing PV employ the intraperitoneal injection route, and it is important to consider whether PV treatment by this route may have unique effects. Our data suggest that intraperitoneal injection of PV suppresses B cells, possibly by influencing regulatory cell function.

Animals↗

PubMed1977

Adenyl cyclase in Bordetella pertussis vaccines.

Brodetella pertussis organisms have a large amount of extracytoplasmic adenyl cyclase, part of which is found in the supernatant culture medium during exponential growth. The enzyme differs from previously studied bacterial adenyl cyclases in biochemical characteristics as well as in location. Several commercial pertussis vaccines were found to contain adenyl cyclase activity; this activity is probably due to the extracytoplasmic enzyme associated with and released from the whole cells in the vaccine.

Adenylyl Cyclases↗

PubMed1978

[Methods of determination of toxicity of pertussis vaccine. 1. Change in the weight of the thymus gland and the spleen in mice after administration of pertussis vaccine].

Experiments were conducted on mice, strain NIH, line HSFS/N, immunized with pertussis vaccine. Determination of thymocyte pool proved to be a more sensitive method of detection of the stress effect of the vaccine than determination of the thymus weight. The test can be used for the elaboration of the method of assessment of the toxicity of pertussis preparations.

Animals↗

PubMed1979

Effect of histamine on respiratory movements and isolated ileum of pertussis-vaccinated mice. A negative study.

1. The sensitivity of mice, of the Swiss random bred strain, previously i.p. vaccinated with Bordetella pertussis Phase I cells, to histamine was investigated. 2. No response and no increase of the sensitivity of the respiratory system of the pertussis-vaccinated mice was observed during and after the inhaled histamine. 3. No contractions and no response of the isolated perfused ileum of the pertussis-vaccinated mice were observed after the addition of histamine. 4. No experimental or control mouse died during the whole experiment.

Aerosols↗

PubMedDate not supplied

An evaluation of pertussis vaccine.

Infant mortality from pertussis in the United States was 4.5 deaths/1,000 in 1900 but decreased to 0.003 deaths/1,000 by 1974. The attribution of this decrease in mortality to the widespread use of pertussis vaccine, which began in the 1940s, has been questioned because death rates from pertussis in infants steadily declined by 70% between 1900-1904 and 1935-1939. Thes doubts are compounded by the uncertain frequency and significance of untoward reactions to the vaccine. An attempt was made to clarify this issue by statistical analysis. Because most deaths from pertussis occur in the young, death rates were determined for consecutive five-year periods from 1900 through 1974 among children younger than one year of age (infants) and among those from one to four years of age. there was an accelerated decline in mortality beginning in 1940, especially among infants (P < 0.01 vs. mortality in 1930-1939). On the basis of the rate of decline before 1940, 4,000-8,000 deaths from pertussis would be expected to hve occurred in 1970-1974; however, only 52 such deaths occurred. It is unlikely that factors other than pertussis vaccine caused this decline in mortality. Therefore, the vaccine's benefit-risk ratio probably is high.

Central America↗

PubMed1978

Reactions after pertussis vaccine: a manufacturer's experiences and difficulties since 1964.

Pertussis vaccines vary in quality, safety, and efficacy according to the production strains of Bordetella pertussis, the method of manufacture, and quality control procedures. It is therefore not justifiable to combine information on the incidence, nature, and severity of reactions after all manufacturers' pertussis vaccines as if they were a single product. Attempts were made to collect information on all suspected cases of severe reactions that occurred after administration of about 15 million doses of Wellcome pertussis vaccines in the United Kingdom and Northern Ireland from 1964 to mid-1977. Altogether six deaths, six neurological reactions with sequelae, and 17 convulsions without sequelae were reported, but some were clearly not attributable to the vaccine, while, in other cases, the available information was inadequate for assessing the role of vaccination. Neurological disorders, similar to those reported in a few children after pertussis vaccination, occur unexpectedly in apparently healthy infants at the recommended age for immunisation, so chance association between vaccination and these events can be expected in some children. The Joint Committee on Vaccination and Immunisation has made several recommendations aimed at reducing severe reactions after pertussis vaccination. These include replacing plain vaccine with aluminium-adsorbed vaccine, but there is no clear evidence that the aluminium-adsorbed vaccine produces fewer reactions than the plain.There are difficulties enough in deciding the cause of events that occur after vaccination, since these reactions often occur naturally in children of vaccination age. The task is made even harder by the assumption that various manufacturers' vaccines are the same and the lack of information available to manufacturers about cases in which their vaccine has been implicated. Information on vaccines administered is entered on immunisation records cards; it should be used and referred to if reactions occur.

Bordetella pertussis↗

PubMed1978

On the relationship between inflammation and altered cAMP metabolism in lungs of B pertussis-vaccinated mice.

Bordetella pertussis-vaccinated mice were examined for evidence of inflammation. Using polymorphonuclear leukocyte and fluid accumulation as markers, inflammation was evidenced in the lungs and to a lesser extent in the livers of such mice. Both heart and kidney showed no evidence of inflammation. Development of the inflammatory lesion followed a time course similar to that previously reported for increased sensitivity to histamine-mediated cAMP accumulation. This close parrallelism between inflammation and altered cAMP metabolism supports the hypothesis that the increased cAMP accumulation might be related to a feedback mechanism regulating inflammatory mediator release.

Animals↗

PubMed1977

[Comparison between two types of pertussis vaccines].

We have produced pertussis vaccines with laboratory and industrial methods. The characteristic of laboratory cultivation of microorganisms is, in this context, growth on Hornibrook medium in low form flask and in stationary culture. Industrial cultivation is done in homogenous culture on a B-2 medium in fermentor. The strains utilized were isolated from whooping-cough cases in the Montreal region. The yield (org. x 10(9)/ml) obtained with an industrial cultivation of B. pertussis was 4 to 7 times higher than that reached with a laboratory cultivation of this microorganism. The non-toxicity as expressed in weight gain of mice was shown for both types of vaccine. The vaccines produced in fermentor were less histamino sensibilizing for mice than the one produced in stationary flash culture. The quality of the vaccines achieved by industrial method is easily reproducible due to the fact that enough variables can be measured.

Bordetella pertussis↗

PubMed1978

[Opsonizing activity of sera from animals immunized with pertussis vaccine].

Opsonizing activity of guinea pig blood serum containing mercaptoethanol-resistant pertussis antibodies was studied in vitro on a model of microorganism ingestion by the mononuclears of the guinea pig peritoneal exudate. There were revealed distinct differences in the serum activity depending on the phagocytosis object. The blood serum of hyperimmunized rabbits stimulated the ingestion of Bordetella pertussis by mononuclears of guinea pigs--normal and immunized with pertussis vaccine. The blood sera of hyperimmunized guinea pigs and of mice immunized with pertussis vaccine twice displayed opsonins to B. pertussis. The blood sera of animals immunized with pertussis vaccine inhibited the staphylococcus ingestion by the peritoneal exudate mononuclears of guinea pigs, both normal and those immunized with pertussis vaccine.

Animals↗

PubMed1979

Effect of Bordetella pertussis vaccine on the course of lymphocytic choriomeningitis (LCM) virus infection in suckling mice pretreated with dianhydrodulcitol (DAD).

In earlier experiments Bordetella pertussis vaccine was found to enhance and dianhydrodulcitol (DAD) to weaken cellular immune response to intracerebral LCM virus infection in suckling mice. B. pertussis vaccine proved to inhibit the restrictive effect of DAD produced on the immune response in mice when 2-to-4-days-old animals were pretreated with DAD and subsequently, at the age of 16 to 18 days of life, treated with B. pertussis vaccine then infected with LCM virus. Consequently, B. pertussis vaccine enhanced the immune response previously affected by DAD.

Animals↗

PubMed1976

The effects of Bordetella pertussis vaccine on cerebral vascular permeability.

The effect of Bordetella pertussis vaccine on the cerebral vascular permeability in the mouse was studied by a radio-isotope method (131I-labelled HSA). Intravenous injection of 4 x 1010 heat-killed pertussis organisms caused a measurable increase in permeability in normal mice. Cryoinjury to the cerebral hemispheres resulted in a striking increase in vascular permeability at 24 h. This declined within 48 h and stabilized at a level fractionally higher than normal at 7 days ("healed lesion"). When pertussis organisms were injected into mice bearing ("healed lesion"). When pertussis organisms were injected into mice bearing "healed lesions" the increase in permeability was similar in magnitude to that in uninjured brain. The effect was increased by a second administration of pertussis 24 h after the first. The action of pertussis on a newly inflicted cryoinjury was protective. It is suggested that permeability changes in the cerebral vessels may be involved in the evolution of the encephalopathy attributed to the use of Bordetella pertussis vaccine in man.

Animals↗

PubMed1977

Assay of pertussis vaccine toxicity by a rat-paw-oedema method.

A method is described of using the production of oedema in the foot pad of rats as an index of the ability of pertussis vaccines to cause local reactions. At a suitable time after the subcutaneous injection of the vaccine into hind paw of the rat, the foot is excised and weighed. The technique is reproducible and most useful for the detection of oedema produced by pertussis-vaccine components sensitive to heating at 80 degrees C for 30 min. Substances in pertussis vaccine that produce rat-paw oedema gave maximal reactions at 4 and 12 h. but were best differentiated 9 h after injection.

Animals↗

PubMed1978

A semi quantitative method for cyclic nucleotide localization by immunocytochemistry and its application in determining the distribution of cyclic AMP in lungs of normal and pertussis-vaccinated mice following histamine or epinephrine challenge.

A method is described which allows quantitative comparison of cAMP content determined by immunocytochemical procedures. This technique was then employed to localize cAMP in lungs of normal and pertussis-vaccinated mice following saline, histamine, or epinephrine challenge. All primary pulmonary compartments were shown to contain some immunoreactive (cAMP) material. However, epinephrine and histamine challenge selectively increased the cAMP content of the vasculature. No effect of epinephrine or histamine was detected in bronchial smooth muscle or interstitial tissue. This increased cAMP accumulation was observed in both normal and pertussis-vaccinated mice following epinephrine challenge but only in pertussis-vaccinated mice after histamine administration. These results demonstrate that histamine and epinephrine stimulate cAMP accumulation in the same pulmonary compartments supporting earlier speculation that histamine acts indirectly through epinephrine release. Further, primary involvement of the vasculature supports a more prominent role for this tissue in pertussis mediated histamine hypersensitivity.

Animals↗

PubMed1977

The insulin-like action of Bordetella pertussis vaccine in rats.

Treatment of rats with Bordetella pertussis vaccine significantly lowered the blood sugar level 4 days later but the vaccine did not alter the level in diabetic rats. The vaccine, like insulin, raised glycogen levels in liver, skeletal muscle and heart and reduced the plasma free fatty acid concentration. The action of a beta-adrenoceptor blocker was potentiated by the vaccine but not by insulin. Part of the hypoglycaemic action of the vaccine is probably due to beta-adrenoceptor blockade.

Adrenergic beta-Antagonists↗

PubMed1979

Adverse reactions after pertussis vaccination.

During 1970 to 1977 adverse reactions after pertussis vaccination were reported for 149 persons, 56% male and 44% female. Their symptoms permitted to divide the vaccinees into 2 groups, the first with more severe (S) and the second with other symptoms (O). No differences were observed in age and sex among the two groups. The interval between vaccination and appearance of first symptoms was longer for the O than for the S group. While less than one quarter of the reactions in the O group occurred after primovaccination, more than half of the S side effects were seen after the first vaccination. Further analysis of the S group revealed that all but two of their symptoms (fever and encephalopatht) corresponded to the hypoglycaemic syndrome. The consequences hereof are discussed with regard to prevention and therapy.

Child↗

PubMed1975

Respiratory and humoral immune response to aerosol and intramuscular pertussis vaccine.

Animal experiments have shown that respiratory administration of pertussis antigen induces a protective immune response. In this study pertussis antibody in human respiratory secretions was measured and the response to aerosol and intramuscular pertussis immunization investigated. Substanial increases in this antibody occurred after aerosol immunization but no changes were found in serum antibody. The reverse was observed after intramuscular pertussis vaccine in adults but not with aerosol immunization. The latter method may be of value for paediatric medical and nursing personnel exposed to the risk of pertussis infection.

Aerosols↗

PubMed1975

Use of pertussis vaccine in an epidemic involving hospital staff.

An epidemic of pertussis occurred among hospital staff caring for paediatric patients. Eight physicians and five nurses were affected. Pertussis developed in six newborn infants exposed to infected hospital staff in the nursery. Erythromycin prophylaxis was used to control the epidemic. Clinical pertussis developed in five adults infected with Bordetella pertussis before erythromycin was used, whereas symptoms developed in only one of the eight adults who became infected after erythromycin prophylaxis was started. Pertussis vaccine was given to adult volunteers in the hospital, and in 77% of two hundred and eighty-six vaccinees there was a fourfold rise in pertussis agglutinins. Local reactions were common, and in two vaccinees generalised rashes developed. One of these required treatment with corticosteroids. The risk of pertussis occurring in adults providing medical care for children should be recognised, and employees with symptoms should be removed from the hospital environment.

Adolescent↗

PubMed1976

Experimental allergic encephalitis (EAE) in mice: histological studies on EAE induced by myelin basic protein, and role of pertussis vaccine.

The histological evidence of EAE in mice was presented to show the identity with those of other species of animals. There was a typical perivascular mononuclear cell infiltration. In addition, a hyperacute form was characterized by edema and the infiltration of polymorphs. In vascular lesions, vascular stasis, thrombosis, and hemorrhage were observed. As for the effect of pertussis vaccine used in the induction of mouse EAE, responsiveness to the histamine sensitizing factor was not directly correlated to the incidence of EAE. However, the intravenous administration of pertussis vaccine caused remarkable leukocytosis, which might play a certain role in mouse EAE induction.

Animals↗